Annual Accounts Receivable
$313.37 M
+$16.59 M+5.59%
December 31, 2023
Summary
- As of February 12, 2025, AMED annual accounts receivable is $313.37 million, with the most recent change of +$16.59 million (+5.59%) on December 31, 2023.
- During the last 3 years, AMED annual accounts receivable has risen by +$58.23 million (+22.82%).
- AMED annual accounts receivable is now at all-time high.
Performance
AMED Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$301.05 M
-$55.86 M-15.65%
September 1, 2024
Summary
- As of February 12, 2025, AMED quarterly accounts receivable is $301.05 million, with the most recent change of -$55.86 million (-15.65%) on September 1, 2024.
- Over the past year, AMED quarterly accounts receivable has dropped by -$12.32 million (-3.93%).
- AMED quarterly accounts receivable is now -16.23% below its all-time high of $359.36 million, reached on March 31, 2024.
Performance
AMED Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AMED Accounts Receivable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +5.6% | -3.9% |
3 y3 years | +22.8% | +2.4% |
5 y5 years | +65.8% | +2.4% |
AMED Accounts Receivable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +14.0% | -16.2% | +9.5% |
5 y | 5-year | at high | +31.9% | -16.2% | +26.7% |
alltime | all time | at high | +4628.0% | -16.2% | +6734.3% |
Amedisys Accounts Receivable History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $301.05 M(-15.7%) |
Jun 2024 | - | $356.91 M(-0.7%) |
Mar 2024 | - | $359.36 M(+14.7%) |
Dec 2023 | $313.37 M(+5.6%) | $313.37 M(-1.9%) |
Sep 2023 | - | $319.58 M(+14.6%) |
Jun 2023 | - | $278.79 M(-5.2%) |
Mar 2023 | - | $294.12 M(-0.9%) |
Dec 2022 | $296.79 M(+7.9%) | $296.79 M(-1.9%) |
Sep 2022 | - | $302.47 M(-1.0%) |
Jun 2022 | - | $305.41 M(+4.0%) |
Mar 2022 | - | $293.58 M(+6.8%) |
Dec 2021 | $274.96 M(+7.8%) | $274.96 M(+0.1%) |
Sep 2021 | - | $274.57 M(-1.3%) |
Jun 2021 | - | $278.22 M(+0.9%) |
Mar 2021 | - | $275.63 M(+8.0%) |
Dec 2020 | $255.15 M(+7.4%) | $255.15 M(+1.7%) |
Sep 2020 | - | $250.78 M(+0.7%) |
Jun 2020 | - | $249.03 M(-7.3%) |
Mar 2020 | - | $268.55 M(+13.0%) |
Dec 2019 | $237.60 M(+25.7%) | $237.60 M(-6.7%) |
Sep 2019 | - | $254.70 M(+6.3%) |
Jun 2019 | - | $239.67 M(+1.4%) |
Mar 2019 | - | $236.44 M(+25.1%) |
Dec 2018 | $188.97 M(-6.1%) | $188.97 M(-3.1%) |
Sep 2018 | - | $195.03 M(-1.3%) |
Jun 2018 | - | $197.59 M(+2.4%) |
Mar 2018 | - | $192.94 M(-4.1%) |
Dec 2017 | $201.20 M(+21.2%) | $201.20 M(+13.4%) |
Sep 2017 | - | $177.40 M(+2.3%) |
Jun 2017 | - | $173.39 M(+0.4%) |
Mar 2017 | - | $172.71 M(+4.0%) |
Dec 2016 | $166.06 M(+32.8%) | $166.06 M(+2.2%) |
Sep 2016 | - | $162.50 M(+6.8%) |
Jun 2016 | - | $152.21 M(-1.1%) |
Mar 2016 | - | $153.86 M(+23.1%) |
Dec 2015 | $125.01 M(+25.9%) | $125.01 M(+2.7%) |
Sep 2015 | - | $121.74 M(+10.2%) |
Jun 2015 | - | $110.45 M(-0.2%) |
Mar 2015 | - | $110.65 M(+11.4%) |
Dec 2014 | $99.33 M(-10.6%) | $99.33 M(-3.4%) |
Sep 2014 | - | $102.86 M(-7.3%) |
Jun 2014 | - | $110.93 M(-3.8%) |
Mar 2014 | - | $115.35 M(+3.8%) |
Dec 2013 | $111.13 M(-34.3%) | $111.13 M(-0.0%) |
Sep 2013 | - | $111.15 M(-10.9%) |
Jun 2013 | - | $124.77 M(-13.8%) |
Mar 2013 | - | $144.66 M(-14.5%) |
Dec 2012 | $169.17 M(+14.3%) | $169.17 M(+3.5%) |
Sep 2012 | - | $163.46 M(+0.2%) |
Jun 2012 | - | $163.16 M(+0.8%) |
Mar 2012 | - | $161.83 M(+9.3%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | $148.06 M(+4.6%) | $148.06 M(-2.1%) |
Sep 2011 | - | $151.21 M(-1.3%) |
Jun 2011 | - | $153.27 M(+8.0%) |
Mar 2011 | - | $141.92 M(+0.3%) |
Dec 2010 | $141.55 M(-5.8%) | $141.55 M(-6.8%) |
Jun 2010 | - | $151.85 M(+0.9%) |
Mar 2010 | - | $150.57 M(+0.2%) |
Dec 2009 | $150.27 M(-14.5%) | $150.27 M(+6.6%) |
Sep 2009 | - | $141.01 M(-8.6%) |
Jun 2009 | - | $154.28 M(-0.1%) |
Mar 2009 | - | $154.37 M(-12.1%) |
Dec 2008 | $175.70 M(+82.4%) | $175.70 M(-2.3%) |
Sep 2008 | - | $179.77 M(+11.1%) |
Jun 2008 | - | $161.86 M(+12.4%) |
Mar 2008 | - | $144.07 M(+49.6%) |
Dec 2007 | $96.31 M(+28.5%) | $96.31 M(+11.3%) |
Sep 2007 | - | $86.55 M(+15.4%) |
Jun 2007 | - | $75.03 M(+10.5%) |
Mar 2007 | - | $67.93 M(-9.3%) |
Dec 2006 | $74.93 M(+10.0%) | $74.93 M(-7.6%) |
Sep 2006 | - | $81.11 M(+27.1%) |
Jun 2006 | - | $63.81 M(-5.3%) |
Mar 2006 | - | $67.40 M(-1.1%) |
Dec 2005 | $68.14 M(+178.4%) | $68.14 M(+15.1%) |
Sep 2005 | - | $59.21 M(+60.1%) |
Jun 2005 | - | $36.99 M(+48.9%) |
Mar 2005 | - | $24.85 M(+1.5%) |
Dec 2004 | $24.48 M(+61.2%) | $24.48 M(+34.0%) |
Sep 2004 | - | $18.27 M(-7.9%) |
Jun 2004 | - | $19.84 M(+33.2%) |
Mar 2004 | - | $14.89 M(-1.9%) |
Dec 2003 | $15.19 M(+7.7%) | $15.19 M(+31.3%) |
Sep 2003 | - | $11.57 M(+22.7%) |
Jun 2003 | - | $9.42 M(-7.9%) |
Mar 2003 | - | $10.23 M(-27.5%) |
Dec 2002 | $14.10 M(-40.5%) | $14.10 M(-5.2%) |
Sep 2002 | - | $14.88 M(-1.5%) |
Jun 2002 | - | $15.11 M(+182.6%) |
Mar 2002 | - | $5.35 M(-77.4%) |
Dec 2001 | $23.68 M(+257.3%) | $23.68 M(+125.2%) |
Sep 2001 | - | $10.52 M(+138.8%) |
Jun 2001 | - | $4.41 M(-54.8%) |
Mar 2001 | - | $9.75 M(+47.2%) |
Dec 2000 | $6.63 M(-52.5%) | $6.63 M(-44.2%) |
Sep 2000 | - | $11.87 M(-2.3%) |
Jun 2000 | - | $12.15 M(+20.4%) |
Mar 2000 | - | $10.10 M(+35.4%) |
Dec 1999 | $13.94 M(+87.0%) | - |
Dec 1998 | $7.46 M(-22.6%) | $7.46 M(-22.6%) |
Dec 1997 | $9.63 M(+16.4%) | $9.63 M(+16.4%) |
Dec 1996 | $8.27 M | $8.27 M |
FAQ
- What is Amedisys annual accounts receivable?
- What is the all time high annual accounts receivable for Amedisys?
- What is Amedisys annual accounts receivable year-on-year change?
- What is Amedisys quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Amedisys?
- What is Amedisys quarterly accounts receivable year-on-year change?
What is Amedisys annual accounts receivable?
The current annual accounts receivable of AMED is $313.37 M
What is the all time high annual accounts receivable for Amedisys?
Amedisys all-time high annual accounts receivable is $313.37 M
What is Amedisys annual accounts receivable year-on-year change?
Over the past year, AMED annual accounts receivable has changed by +$16.59 M (+5.59%)
What is Amedisys quarterly accounts receivable?
The current quarterly accounts receivable of AMED is $301.05 M
What is the all time high quarterly accounts receivable for Amedisys?
Amedisys all-time high quarterly accounts receivable is $359.36 M
What is Amedisys quarterly accounts receivable year-on-year change?
Over the past year, AMED quarterly accounts receivable has changed by -$12.32 M (-3.93%)